导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -8.94% | 808/1050 |
| 近一周 | -3.41% | 882/1104 |
| 近一月 | -4.67% | 572/1102 |
| 近一季 | -9.80% | 652/1092 |
| 近半年 | -17.02% | 935/1070 |
| 近一年 | -7.75% | 707/1018 |
| 近两年 | 28.84% | 689/926 |
| 近三年 | -2.04% | 694/834 |
| 成立以来 | 115.84% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
6.03% 110/1070 |
-10.82% 931/1101 |
- - |
- - |
| 2025 | 11.95% 806/1065 |
0.92% 726/1014 |
1.27% 574/1038 |
7.04% 900/1050 |
2.35% 280/1065 |
| 2024 | 0.89% 557/1011 |
-8.31% 707/960 |
-1.54% 408/983 |
14.89% 235/991 |
-2.74% 513/1011 |
| 2023 | -18.78% 643/952 |
1.46% 543/880 |
-8.64% 716/895 |
-7.20% 445/915 |
-5.58% 566/952 |
| 2022 | -7.17% 53/867 |
-13.73% 209/773 |
15.44% 112/806 |
-11.79% 373/845 |
5.67% 176/867 |
| 2021 | 23.21% 130/740 |
0.03% 150/580 |
15.29% 231/659 |
1.11% 203/704 |
5.67% 199/740 |
| 2020 | 43.20% 279/554 |
-6.67% 332/419 |
24.24% 207/466 |
18.09% 77/517 |
4.58% 445/554 |
| 2019 | 25.67% 309/410 |
12.33% 1038/1149 |
-3.72% 630/1231 |
3.25% 244/390 |
12.54% 103/410 |
| 2018 | -0.80% 3/349 |
- - |
- - |
- - |
-1.27% 15/1080 |
| 2017 | 1.95% 168/285 |
- - |
- - |
- - |
- - |
| 2016 | 2.39% 24/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 南方中小盘成长股票A VS. 东吴新产业精选股票A(580008) |